Posaconazole salvage therapy: The Posifi study.
Jesús FortunFrancesca GioiaCelia CardozoCarlota GudiolElena DiagoJuan José CastónPatricia MuñozJavier LópezPedro Puerta-AlcaldeMatías EnzenhoferAntonio Ramos MartínezAzahara FrutosMarina MachadoCarolina Garcia-VidalRocío ParodyPilar Martín-DávilaPublished in: Mycoses (2019)
Posaconazole salvage therapy, especially oral tablets, can be an effective alternative option for patients with IFI who cannot tolerate or do not respond to other antifungal therapies.